Swiss pharma giant Roche to buy American firm GenMark Diagnostics for $1.8 billion, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Roche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10., Roche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10., , Read More